Lexaria Receives Three Patent Grants and Two Notices of Allowance; Provides Patent Portfolio Guidance

Tickers: XCNQ:LXX, XOTC:LXRP, PINX:LXRPTags: None Kelowna, British Columbia / TheNewswire / September 7, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces strategic additions to its patent portfolio. Three new…